Large Liver Blood Vessels and Bile Ducts Are Not Damaged by Electrochemotherapy with Bleomycin in Pigs

The first clinical studies on the use of electrochemotherapy to treat liver tumours that were not amenable to surgery or thermal ablation techniques have recently been published. However, there is still a lack of data on the effects of electrochemotherapy on normal liver tissue. Therefore, we design...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2019-03, Vol.9 (1), p.3649-3649, Article 3649
Main Authors: Zmuc, Jan, Gasljevic, Gorana, Sersa, Gregor, Edhemovic, Ibrahim, Boc, Nina, Seliskar, Alenka, Plavec, Tanja, Brloznik, Maja, Milevoj, Nina, Brecelj, Erik, Kos, Bor, Izlakar, Jani, Jarm, Tomaz, Snoj, Marko, Stukelj, Marina, Miklavcic, Damijan, Cemazar, Maja
Format: Article
Language:English
Subjects:
Animal models
Bile ducts
Bleomycin
Blood vessels
Inflammation
Liver
Liver cancer
Surgery
Thrombosis
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The first clinical studies on the use of electrochemotherapy to treat liver tumours that were not amenable to surgery or thermal ablation techniques have recently been published. However, there is still a lack of data on the effects of electrochemotherapy on normal liver tissue. Therefore, we designed a translational animal model study to test whether electrochemotherapy with bleomycin causes clinically significant damage to normal liver tissue, with emphasis on large blood vessels and bile ducts. We performed electrochemotherapy with bleomycin or delivered electric pulses alone using a potentially risky treatment strategy in eight pigs. Two and seven days after treatment, livers were explanted, and histological analysis was performed. Blood samples were collected before treatment and again before euthanasia to evaluate blood biomarkers of liver function and systemic inflammatory response. We found no thrombosis or other clinically significant damage to large blood vessels and bile ducts in the liver. No clinical or laboratory findings suggested impaired liver function or systemic inflammatory response. Electrochemotherapy with bleomycin does not cause clinically significant damage to normal liver tissue. Our study provides further evidence that electrochemotherapy with bleomycin is safe for treatment of patients with tumours near large blood vessels in the liver.
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-019-40395-y